Regulatory Focus™ > News Articles > The FDA Amendments Act of 2007—User Fees and More

The FDA Amendments Act of 2007—User Fees and More

Posted 01 February 2008 | By

The Food and Drug Administration Amendments Act of 2007 (FDAAA)1 is legislation that will have far-reaching impact on regulated industry. The act, signed into law on 27 September 2007, re-committed the medical device industry to user fees and averted a financial crisis for FDA that would have significantly reduced the agency's capacity to function. The user fees will provide predictable levels of funding for FDA for the next five years.2

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe